Cargando…
Broadly neutralizing aptamers to SARS-CoV-2: A diverse panel of modified DNA antiviral agents
Since its discovery, COVID-19 has rapidly spread across the globe and has had a massive toll on human health, with infection mortality rates as high as 10%, and a crippling impact on the world economy. Despite numerous advances, there remains an urgent need for accurate and rapid point-of-care diagn...
Autores principales: | Gelinas, Amy D., Tan, Tiong Kit, Liu, Sai, Jaramillo, Javier G., Chadwick, James, Harding, Adam C., Zhang, Chi, Ream, Brian E., Chase, Chelsea N., Otis, Matthew R., Lee, Thomas, Schneider, Daniel J., James, William S., Janjic, Nebojsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859636/ https://www.ncbi.nlm.nih.gov/pubmed/36714461 http://dx.doi.org/10.1016/j.omtn.2023.01.008 |
Ejemplares similares
-
Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents
por: Rohloff, John C, et al.
Publicado: (2014) -
Structural basis for IL-1α recognition by a modified DNA aptamer that specifically inhibits IL-1α signaling
por: Ren, Xiaoming, et al.
Publicado: (2017) -
Modified aptamers as reagents to characterize recombinant human erythropoietin products
por: Jankowski, Wojciech, et al.
Publicado: (2020) -
Fit for the Eye: Aptamers in Ocular Disorders
por: Drolet, Daniel W., et al.
Publicado: (2016) -
Pharmacokinetic Properties of DNA Aptamers with Base Modifications
por: Gupta, Shashi, et al.
Publicado: (2017)